Cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl ]-1-methylcyclohexane-1-carboxamide, alternatively named (1s,4s)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4 -Yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide, or salt or solvate thereof , Hydrate, or isomer production processes are provided herein.시스-4-[2-{[(3S,4R)-3-플루오로옥산-4-일]아미노}-8-(2,4,6-트리클로로아닐리노)-9H-퓨린-9-일]-1-메틸사이클로헥산-1-카르복스아미드, 대안적으로 명명하면 (1s,4s)-4-(2-(((3S,4R)-3-플루오로테트라하이드로-2H-피란-4-일)아미노)-8-((2,4,6-트리클로로페닐)아미노)-9H-퓨린-9-일)-1-메틸사이클로헥산-1-카르복스아미드, 또는 이의 염, 용매화물, 수화물, 또는 동위이성질체 제조 공정이 본원에 제공된다.
